Cancer research in 'golden era', says charity chief
"explosion" in the understanding of the disease could revolutionize the treatment and reduce drug costs
The head of the leading cancer charity in the UK said that the understanding of the disease is increasing "exponentially" as potentially innovative trials to test genetically tumors of 9000 newly diagnosed patients to start .
Descriptiona "golden age" of research, Harpal Kumar, chief executive of Cancer Research UK, said it was "an explosion in our understanding of what is cancer, why it happens, so it can 'in some people and why it moves around the body. "
trials supported by the Department of Health and the Cancer Research UK launch next month in seven hospitals in Britain. Scientists believe that the results could revolutionize cancer treatment.
will aim to find out which existing drugs are susceptible to cancer. Also potentially pave the way for the discovery of new drugs that are personalized or directed at the genetic makeup of an individual cancer and therefore much more efficient.
The two-year project designed to lead to a full deployment of genetic testing of tumors by the NHS. The government has approved to increase the genetic testing as part of the national cancer plan, which Cancer Research UK believes will bring a significant change in the way cancer is treated.
Kumar said: "I will try to present a utopian vision that we know everything, why not, but our knowledge is growing exponentially, we learn a lot over the months go by ...
"It is no exaggeration to say that the future of treatment. This is the future of medicine. This is true not only in cancer, but thanks to medicine in general. "
Most medications for some people but not others. In some diseases, like cancer, working in a relatively small proportion of patients.
"People have known for years that we handle and will work only 20% of the population and now we are about to discover what is happening," said Mr. Kumar.
As the DNA of every individual is different, so cancerous tumors. In the test next month, tumor samples from patients with one of the most common cancers - breast, colon, lung, prostate, melanoma and ovarian -. Will undergo a series of tests
is also possible, says Kumar, the researchers found that the older drugs or work thrown in some patients long after they were dismissed because they had little impact on large populations.
"The most likely already have many tools, but do not know how to use them properly," said Kumar. "We have a good group of drugs and I know they work with many people but not others.
Find best price for : --Research----cancer----Kumar--
0 comments:
Post a Comment